Prospective trial to assess melanoma antigens as biomarker for ipilimumab response
Latest Information Update: 31 May 2017
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Biomarker; Pharmacodynamics
- 31 May 2017 New trial record